Subjects received eTNS nightly as monotherapy for the 8-week study period. ADHD symptom severity and cognitive performance were assessed at baseline, four weeks and eight weeks.
http://www.sys-con.com/node/2621468
http://www.sys-con.com/node/2621468
No comments:
Post a Comment